Treating Neonatal Opioid Withdrawal

The rise in opioid use in the United States has an unpleasant residual effect; an increase in pregnant women suffering from an opioid use disorder. Subsequently, there is a need to treat an increasing number of infants with neonatal opioid withdrawal syndrome (NOWS). This condition can lead to devastating effects for the infant, including severe withdrawal symptoms and development issues.

How is healthcare meeting this challenge? Luckily, clinicians, researchers, and healthcare companies are working on solutions.

On this episode of Vital Spark, a Spark Biomedical podcast, Dan Wagner, Chief Commercial Officer of Spark Biomedical, spoke with two people from the Medical University of South Carolina. They are actively involved in treating this disorder. Dorothea Jenkins, M.D., Professor of Pediatrics, Medical University of South Carolina Division of Neonatology, and Bashar Badran, Ph.D., Assistant Professor in the College of Medicine Department of Psychiatry and the Behavioral Sciences Medical University of South Carolina, spoke about their combined efforts utilizing translational therapies with neurostimulation on babies with NOWS.

Jenkins and Badran discuss:

The effects of certain opioids on the neurology of the brains of babies

New non-evasive brain stimulation treatments to combat NOWS

Learnings from utilizing auricular neurostimulation on babies with NOWS

“We are on track towards the better understanding of reasonable, high-ranking hypothesis that may be the reason why we get such beneficial effects of auricular neurostimulation,” Badran said.”

Dorothea Jenkins, M.D. is a professor of Pediatrics at the Medical University of South Carolina Division of Neonatology who does research and translational therapies for babies with brain injuries. She collaborates with Dr. Bashar Badran on treating babies with neurostimulation with brain injury who are trying to learn motor skills.

Bashard Badran, Ph.D., is an assistant professor in the College of Medicine Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina. He is a neuroscientist who works on brain stimulation research and device development.

 

Follow us on social media for the latest updates in B2B!

Latest

Mapping AI’s role in education
Mapping AI’s Role in Education: Pioneering the Path to the Future
October 2, 2023

Mapping AI’s role in education should be a critical step in bringing together innovative technology-based solutions with the expertise of human educators. With rapid advancements in artificial intelligence and an increased reliance on technology-driven educational solutions, the education landscape is on the brink of a significant transformation. AI promises highly personalized learning experiences, efficient administrative […]

Read More
economic paradigms
Unraveling Ethical & Economic Paradigms: JP Morgan, Epstein, Eric Stewart, and Ibram X. Kendi
October 2, 2023

Recently, controversial affiliations and questionable economic paradigms surrounding the ethical practices of major financial institutions have made headlines. JPMorgan Chase, whose entanglements with the late financier Jeffrey Epstein led to a $75 million settlement in a sex trafficking lawsuit, rekindles the debate on the integrity of mammoth financial entities. In light of a climate […]

Read More
FlowCast: Aftermarket Services Help Businesses Grow And Keep Customers Satisfied
October 2, 2023

In today’s rapidly evolving technological landscape, aftermarket services have become a pivotal aspect of customer satisfaction and business growth. As industries continue to innovate, the demand for efficient, reliable, and high-quality services has surged. A recent study indicates that these services are a significant revenue stream and a key differentiator in the market for businesses. […]

Read More